• Je něco špatně v tomto záznamu ?

The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells

L. Jahangiri, T. Ishola, P. Pucci, RM. Trigg, J. Pereira, JA. Williams, ML. Cavanagh, GV. Gkoutos, L. Tsaprouni, SD. Turner

. 2021 ; 13 (6) : . [pub] 20210311

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018181

Cancer stem cells (CSCs) possess properties such as self-renewal, resistance to apoptotic cues, quiescence, and DNA-damage repair capacity. Moreover, CSCs strongly influence the tumour microenvironment (TME) and may account for cancer progression, recurrence, and relapse. CSCs represent a distinct subpopulation in tumours and the detection, characterisation, and understanding of the regulatory landscape and cellular processes that govern their maintenance may pave the way to improving prognosis, selective targeted therapy, and therapy outcomes. In this review, we have discussed the characteristics of CSCs identified in various cancer types and the role of autophagy and long noncoding RNAs (lncRNAs) in maintaining the homeostasis of CSCs. Further, we have discussed methods to detect CSCs and strategies for treatment and relapse, taking into account the requirement to inhibit CSC growth and survival within the complex backdrop of cellular processes, microenvironmental interactions, and regulatory networks associated with cancer. Finally, we critique the computationally reinforced triangle of factors inclusive of CSC properties, the process of autophagy, and lncRNA and their associated networks with respect to hypoxia, epithelial-to-mesenchymal transition (EMT), and signalling pathways.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018181
003      
CZ-PrNML
005      
20210729104147.0
007      
ta
008      
210726s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers13061239 $2 doi
035    __
$a (PubMed)33799834
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jahangiri, Leila $u Department of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK $u Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK
245    14
$a The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells / $c L. Jahangiri, T. Ishola, P. Pucci, RM. Trigg, J. Pereira, JA. Williams, ML. Cavanagh, GV. Gkoutos, L. Tsaprouni, SD. Turner
520    9_
$a Cancer stem cells (CSCs) possess properties such as self-renewal, resistance to apoptotic cues, quiescence, and DNA-damage repair capacity. Moreover, CSCs strongly influence the tumour microenvironment (TME) and may account for cancer progression, recurrence, and relapse. CSCs represent a distinct subpopulation in tumours and the detection, characterisation, and understanding of the regulatory landscape and cellular processes that govern their maintenance may pave the way to improving prognosis, selective targeted therapy, and therapy outcomes. In this review, we have discussed the characteristics of CSCs identified in various cancer types and the role of autophagy and long noncoding RNAs (lncRNAs) in maintaining the homeostasis of CSCs. Further, we have discussed methods to detect CSCs and strategies for treatment and relapse, taking into account the requirement to inhibit CSC growth and survival within the complex backdrop of cellular processes, microenvironmental interactions, and regulatory networks associated with cancer. Finally, we critique the computationally reinforced triangle of factors inclusive of CSC properties, the process of autophagy, and lncRNA and their associated networks with respect to hypoxia, epithelial-to-mesenchymal transition (EMT), and signalling pathways.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Ishola, Tala $u Department of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK
700    1_
$a Pucci, Perla $u Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK
700    1_
$a Trigg, Ricky M $u Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK $u Department of Functional Genomics, GlaxoSmithKline, Stevenage SG1 2NY, UK
700    1_
$a Pereira, Joao $u Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
700    1_
$a Williams, John A $u Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK $u Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2SY, UK
700    1_
$a Cavanagh, Megan L $u Department of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK
700    1_
$a Gkoutos, Georgios V $u Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK $u Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2SY, UK $u Mammalian Genetics Unit, Medical Research Council Harwell Institute, Oxfordshire OX110RD, UK $u MRC Health Data Research Midlands, University of Birmingham, Birmingham B15 2TT, UK $u NIHR Experimental Cancer Medicine Centre, Birmingham B15 2TT, UK $u NIHR Surgical Reconstruction and Microbiology Research Centre, Birmingham B15 2TT, UK $u NIHR Biomedical Research Centre, Birmingham B15 2TT, UK
700    1_
$a Tsaprouni, Loukia $u Department of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK
700    1_
$a Turner, Suzanne D $u Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK $u Central European Institute of Technology (CEITEC), Masaryk University, 625 00 Brno, Czech Republic
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 13, č. 6 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33799834 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210726 $b ABA008
991    __
$a 20210729104146 $b ABA008
999    __
$a ind $b bmc $g 1676568 $s 1138625
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 13 $c 6 $e 20210311 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
LZP    __
$a Pubmed-20210726
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace